J. D. Stanaway, A. D. Flaxman, M. Naghavi, C. Fitzmaurice, T. Vos et al., The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study, Lancet, vol.388, pp.30579-30586, 2013.

, Global health sector strategy on viral hepatitis, 2016.

, Switzerland: Geneva, WHO. Global hepatitis report, 2017.

, WHO. Guidelines on hepatitis B and C testing, 2017.

H. F. Njai, Y. Shimakawa, B. Sanneh, L. Ferguson, G. Ndow et al., Validation of rapid point-of-care (POC) tests for the detection of hepatitis B surface antigen (HBsAg) in field and laboratory settings in The Gambia, West Africa, J Clin Microbiol, vol.53, pp.1156-1163, 2015.

M. Lemoine, Y. Shimakawa, R. Njie, M. Taal, G. Ndow et al., Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study, Lancet Glob Heal, vol.4, pp.30130-30139, 2016.

S. Nayagam, L. Conteh, E. Sicuri, Y. Shimakawa, P. Suso et al., Costeffectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis, Lancet Glob Heal, vol.4, pp.30101-30103, 2016.

, European Association for the Study of the Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection, J Hepatol, vol.57, pp.167-185, 2012.

N. A. Terrault, N. H. Bzowej, K. Chang, J. P. Hwang, M. M. Jonas et al., AASLD guidelines for treatment of chronic hepatitis B, Hepatology, vol.63, pp.261-283, 2016.

S. K. Sarin, M. Kumar, G. K. Lau, Z. Abbas, H. Chan et al., AsianPacific clinical practice guidelines on the management of hepatitis B: a 2015 update, Hepatol Int, vol.10, pp.1-98, 2016.

M. Lemoine, S. Eholié, and K. Lacombe, Reducing the neglected burden of viral hepatitis in Africa: strategies for a global approach, J Hepatol, vol.62, pp.469-476, 2015.

S. F. Andriamandimby, M. Olive, Y. Shimakawa, F. Rakotomanana, I. M. Razanajatovo et al., Prevalence of chronic hepatitis B virus infection and infrastructure for its diagnosis in Madagascar: implication for the WHO's elimination strategy, BMC Public Health, vol.17, p.636, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01653384

, Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection, 2015.

H. I. Yang, M. F. Yuen, H. L. Chan, K. H. Han, P. J. Chen et al., Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACHB): development and validation of a predictive score, Lancet Oncol, vol.12, issue.11, pp.70077-70085, 2011.

Y. Shimakawa, M. Lemoine, H. F. Njai, C. Bottomley, G. Ndow et al., Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia, Gut, vol.65, pp.2007-2016, 2016.

M. Lemoine, Y. Shimakawa, R. Njie, H. F. Njai, S. Nayagam et al., Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: the PROLIFICA experience in The Gambia, Aliment Pharmacol Ther, vol.39, pp.188-196, 2014.

S. Ghosh, A. Sow, C. Guillot, A. Jeng, G. Ndow et al., Implementation of an in-house quantitative real-time polymerase chain reaction method for Hepatitis B virus quantification in West African countries, J Viral Hepat, vol.23, pp.897-904, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01792611

M. Lemoine, Y. Shimakawa, S. Nayagam, M. Khalil, P. Suso et al., The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa, Gut, vol.65, pp.1369-1376, 2016.

J. Boursier, J. P. Zarski, V. De-ledinghen, M. C. Rousselet, N. Sturm et al., Determination of reliability criteria for liver stiffness evaluation by transient elastography, Hepatology, vol.57, pp.1182-1191, 2013.

V. Wong, S. L. Chan, F. Mo, T. C. Chan, H. Loong et al., Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers, J Clin Oncol, vol.28, pp.1660-1665, 2010.

H. Yang, M. Sherman, J. Su, P. Chen, Y. Liaw et al., Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection, J Clin Oncol, vol.28, pp.2437-2444, 2010.

G. Wong, H. Chan, C. Wong, C. Leung, C. Y. Chan et al., Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B, J Hepatol, vol.60, pp.339-345, 2014.

Y. Shimakawa, E. Bah, C. P. Wild, and A. J. Hall, Evaluation of data quality at the Gambia National Cancer Registry, Int J Cancer, vol.132, pp.658-665, 2013.

P. S. Mbaye, A. Sarr, J. Sire, M. Evra, A. Ba et al., Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral load, PLoS One, vol.6, 2011.

P. Bonnard, R. Sombié, F. Lescure, A. Bougouma, J. B. Guiard-schmid et al., Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)infected patients in Burkina Faso, Am J Trop Med Hyg, vol.82, pp.454-458, 2010.

L. M. Sullivan, J. M. Massaro, D. Agostino, and R. B. , Presentation of multivariate data for clinical use: The Framingham Study risk score functions, Stat Med, vol.23, pp.1631-1660, 2004.

D. G. Altman, Y. Vergouwe, P. Royston, and K. Moons, Prognosis and prognostic research: validating a prognostic model, BMJ, vol.338, p.605, 2009.

T. Byrt, J. Bishop, and J. B. Carlin, Bias, prevalence and kappa, J Clin Epidemiol, vol.46, pp.423-429, 1993.

P. M. Bossuyt, J. B. Reitsma, D. E. Bruns, C. A. Gatsonis, P. Paul et al., STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies, BMJ, vol.351, 2015.

A. Jaquet, M. Nouaman, J. Tine, A. Tanon, C. Anoma et al., Hepatitis B treatment eligibility in West Africa: uncertainties and need for prospective cohort studies, Liver Int, vol.37, pp.1116-1121, 2017.

H. Aberra, H. Desalegn, N. Berhe, G. Medhin, K. Stene-johansen et al., Early experiences from one of the first treatment programs for chronic hepatitis B in sub-Saharan Africa, BMC Infect Dis, vol.17, p.438, 2017.

M. Chang, Natural history and clinical management of chronic hepatitis B virus infection in children, Hepatol Int, vol.2, pp.28-36, 2008.

A. Evans, A. Connell, J. C. Pugh, and S. Mason, Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma, Cancer Epidemiol Biomarkers Prev, vol.7, pp.559-565, 1998.

C. J. Chen, H. I. Yang, J. Su, C. L. Jen, S. L. You et al., Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level, JAMA, vol.295, pp.65-73, 2006.

M. E. Mendy, T. Welzel, O. A. Lesi, P. Hainaut, A. J. Hall et al., Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa, J Viral Hepat, vol.17, pp.115-122, 2010.

W. World, Health Organization model list of essential in vitro diagnostics, 2018.

F. Clement, P. Dewint, and G. Leroux-roels, Evaluation of a new rapid test for the combined detection of hepatitis B virus surface antigen and hepatitis B virus e antigen, J Clin Microbiol, vol.40, pp.4603-4606, 2002.

S. Jain, R. Rajasingham, F. Noubary, E. Coonahan, R. Schoeplein et al., Performance of an optimized paper-based test for rapid visual measurement of alanine aminotransferase (ALT) in fingerstick and venipuncture samples, PLoS One, vol.10, pp.1-15, 2015.

S. Nayagam, M. Thursz, E. Sicuri, L. Conteh, S. Wiktor et al., Requirements for global elimination of hepatitis B: A modelling study, Lancet Infect Dis, vol.16, issue.16, pp.30204-30207, 2016.

M. J. Tong, C. Hsien, L. Hsu, H. Sun, and L. M. Blatt, Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States, Hepatology, vol.48, pp.1070-1078, 2008.